H2RC87 (H2RC87_PANTR) Pan troglodytes (Chimpanzee)

Stratifin UniProtKBInterProSTRINGInteractive Modelling

248 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: P31947; Pan troglodytes: A0A6D2X694; Pan paniscus: A0A2R8ZKA8; Gorilla gorilla gorilla: G3R777; Nomascus leucogenys: G1SAD1

Available Structures

437 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer)
3iqu
 Heteromer
P04049; P31947; 		1-231
2×CL; 6×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1014
7az2
 Heteromer
P31947; Q13526; 		1-231
2×SFW; 4×CA; 2×CL;
Assess
Co-soaked stabilizers for ERa - 14-3-3 interaction (844_AZ210)
8bzw
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×SSX; 2×GEH;
Assess
Co-soaked stabilizers for ERa - 14-3-3 interaction (884_AZ354)
8c04
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×GEH; 2×LF5;
Assess
Cys-42-tethered stabilizer 12 of 14-3-3(sigma)/ERa PPI
7baa
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T5Z;
Assess
co-soaked stabilizers for ERa - 14-3-3 interaction (884_AZ244)
8bzc
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×GEH; 2×SG0;
Assess
14-3-3 sigma sirtuin-3 phospho-peptide complex
8anc
 Heteromer
P31947; Q9NTG7; 		1-231
6×MG; 4×CA; 2×CL;
Assess
14-3-3 sigma in complex with IkappaBalpha pS63 peptide
6y1j
 Heteromer
P25963; P31947; 		1-231
4×CA; 2×CL; 2×MG; 14×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 in complex with DP005
6nv2
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×0V4;
Assess
14-3-3sigma in complex with a P129beta3P mutated YAP pS127 phosphopeptide
6g6x
 Heteromer
P31947; P46937; 		1-231
8×CL; 4×NA;
Assess
14-3-3 sigma in complex with YAP pS127-peptide
3mhr
 Heteromer
P31947; P46937; 		1-231
8×MG; 8×CL; 2×CA; 6×GOL;
Assess
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (10mer)
3iqj
 Heteromer
P04049; P31947; 		1-231
2×CL; 6×MG;
Assess
Cys-45-tethered stabilizer 4 of 14-3-3(sigma)/ERa PPI
7b9r
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×T4Q;
Assess
Cys-45-tethered stabilizer 5 of 14-3-3(sigma)/ERa PPI
7b9t
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T4Z;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1013
7az1
 Heteromer
P31947; Q13526; 		1-231
2×SGH; 4×CA; 2×CL;
Assess
Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide
7nfw
 Heteromer
P03372; P31947; 		1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-182
7nxw
 Heteromer
P31947; Q04206; 		1-231
2×UVZ; 4×CL; 2×MG; 2×PEG;
Assess
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) and stabilisator Fusico…
3iqv
 Heteromer
P04049; P31947; 		1-231
2×FSC; 4×CL; 8×MG;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074372)
8bx3
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×RZL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-185
7nws
 Heteromer
P31947; Q04206; 		1-231
2×UT8; 4×CL; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-184
7nxs
 Heteromer
P31947; Q04206; 		1-231
2×UVK; 2×CL; 2×MG; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-180
7biq
 Heteromer
P31947; Q04206; 		1-231
2×TVB; 6×CA; 4×CL; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-183
7nxt
 Heteromer
P31947; Q04206; 		1-231
2×UVE; 4×CL; 2×MG; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-188
7nv4
 Heteromer
P31947; Q04206; 		1-231
2×UST; 4×CL; 2×MG; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-179
7bi3
 Heteromer
P31947; Q04206; 		1-231
2×TQW; 2×GOL; 4×CA; 2×CL; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-046
7o3a
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V0T; 2×CA; 2×GOL; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45
6qhl
 Heteromer
P31947; Q04206; 		1-231
4×GOL;
Assess
Fragment AZ-003 binding at the TAZpS89/14-3-3 sigma interface
6rhc
 Heteromer
P31947; Q9GZV5; 		1-231
6×MG; 4×CL; 2×K48;
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide
5mhc
 Heteromer
P04637; P31947; 		1-231
2×CA; 2×MG;
Assess
Cys-42-tethered stabilizer 10 of 14-3-3(sigma)/ERa PPI
7ba8
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×T6H;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-043
7o34
 Heteromer
P31947; Q04206; 		1-231
2×V0Q; 2×MG;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074361)
8byo
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×U0L;
Assess
14-3-3 sigma bound to bis-phosphorylated aminopeptidase N (APN, CD13) via canonical and non-canonic…
7aew
 Heteromer
P15144; P31947; 		1-231
8×NA; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-192
7o59
 Heteromer
P31947; Q04206; 		1-231
2×V2N; 2×V2K; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-187
7biw
 Heteromer
P31947; Q04206; 		1-231
2×TW8; 4×CA; 2×CL; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-186
7nvi
 Heteromer
P31947; Q04206; 		1-231
2×USW; 4×CL; 2×MG; 2×PEG;
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C45 mutant bound to disulfide f…
6hmu
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×GE8;
Assess
single soak stabilizer for ERa - 14-3-3 interaction (AZ275)
8bz0
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×SDM;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-181
7nxy
 Heteromer
P31947; Q04206; 		1-231
2×UVQ; 4×CL; 2×MG; 2×PEG;
Assess
14-3-3sigma covalently bound to peptide (chloroacetamide-Cys interaction)
7o07
 Heteromer
P31947; P46937; 		1-231
8×MG;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074361)
8bxi
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×S0O;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1083744)
8aps
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NJ3;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521
6yow
 Heteromer
P31947; Q04206; 		1-231
2×L3Y;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound LvD1009
7nqp
 Heteromer
P31947; Q04206; 		1-231
2×TJ8; 2×MG;
Assess
single soak stabilizer for ERa - 14-3-3 interaction (AZ555)
8bza
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×L1T;
Assess
14-3-3 sigma with RelA/p65 binding site pS281
6qhm
 Heteromer
P31947; Q04206; 		1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2e-I with 14-3-3sigma
6fau
 Heteromer
P10636; P31947; 		1-231
7×NA; 2×D3W; 2×CL;
Assess
14-3-3sigma in complex with a S131beta3S mutated YAP pS127 phosphopeptide
6g8k
 Heteromer
P31947; P46937; 		1-231
4×CL; 2×MG; 2×NA;
Assess
Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide
7np2
 Heteromer
P31947; Q4VCS5; 		1-231
2×MG; 2×CL;
Assess
Fragment AZ-018 binding at the TAZpS89/14-3-3 sigma interface
6rjl
 Heteromer
P31947; Q9GZV5; 		1-231
2×K5Z;
Assess
Binary complex of 14-3-3 sigma and p53 pT387-peptide
3lw1
 Heteromer
P04637; P31947; 		1-231
6×MG; 2×CL; 2×GOL;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…
6y18
 Heteromer
P31947; P62508; 		1-231
2×MG; 2×CL; 2×O68;
Assess
14-3-3 sigma in complex with SMAD2 pS465 peptide
6yia
 Heteromer
P31947; Q15796; 		1-231
10×MG; 2×GOL; 2×CL; 2×CA; 2×NA;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…
6xxc
 Heteromer
P31947; P62508; 		1-231
6×MG; 2×CL; 2×O3W;
Assess
Fragment AZ-003 binding at the p53pT387/14-3-3 sigma interface
6rl3
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×GOL; 2×K48;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…
6xy5
 Heteromer
P31947; P62508; 		1-231
4×MG; 2×CL; 2×O4E;
Assess
Cys-42-tethered stabilizer 13 of 14-3-3(sigma)/ERa PPI
7bab
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T6W;
Assess
Crystal structure of 14-3-3 sigma in complex with wild-type Shroom3
6fbb
 Heteromer
P31947; Q8TF72; 		1-231
4×MG; 4×CL;
Assess
single soak stabilizer for ERa - 14-3-3 interaction (AZ354)
8bz9
 Heteromer
P03372; P31947; 		1-231
4×MG; 4×LF5;
Assess
Human 14-3-3 sigma in complex with human MDM2 peptide
8p0d
 Heteromer
P31947; Q00987; 		1-231
2×GOL; 2×PEG; 2×CL; 4×MG;
Assess
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935
5my9
 Heteromer
P31947; Q5S007; 		1-231
6×CA; 2×CL;
Assess
14-3-3 sigma with p65 (RelA) binding site pS45 and covalently bound PC2046
7nsv
 Heteromer
P31947; Q04206; 		1-231
2×UQN; 2×GOL;
Assess
Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ177
7oqs
 Heteromer
P31947; Q4VCS5; 		1-231
2×0BS; 2×MG;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…
6y3w
 Heteromer
P31947; P62508; 		1-231
6×MG; 2×CL; 2×O85;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076394)
8arr
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×NK6;
Assess
Small molecule stabilizer (compound 1) for ERalpha and 14-3-3
8afn
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×O6C;
Assess
14-3-3sigma in complex with a L132beta3L mutated YAP pS127 phosphopeptide
6g8l
 Heteromer
P31947; P46937; 		1-231
2×CL; 2×MG; 2×NA;
Assess
Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 22
7npg
 Heteromer
P31947; Q4VCS5; 		1-231
2×K92; 4×CA; 2×CL; 2×MG;
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV3
5n5w
 Heteromer
P31947; Q9GZV5; 		1-231
6×MG; 4×CL; 2×CA; 2×8OE;
Assess
Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 09
7npb
 Heteromer
P31947; Q4VCS5; 		1-231
2×K7N; 4×CA; 2×CL;
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (DBD) phosphopeptide
6y1d
 Heteromer
P31947; P62508; 		1-231
2×MG; 2×CL;
Assess
Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ180
7oqu
 Heteromer
P31947; Q4VCS5; 		1-231
2×0BL; 2×CL; 4×MG;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 7
8bm5
 Heteromer
P31947; P62508; 		1-231
6×MG; 2×CL; 2×QQ0;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-124
7nk5
 Heteromer
P31947; Q04206; 		1-231
2×UGN; 2×CA; 2×GOL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3sigma (1074378)
8arx
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NR6;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-070
7nmh
 Heteromer
P31947; Q04206; 		1-231
2×GOL; 2×CA; 2×UHZ; 2×CL; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-153
7bkh
 Heteromer
P31947; Q04206; 		1-231
4×U1B;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-083
7o6j
 Heteromer
P31947; Q04206; 		1-231
6×V48; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-133
7nj9
 Heteromer
P31947; Q04206; 		1-231
2×UGE; 2×PEG;
Assess
Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075306)
8ats
 Heteromer
P04049; P31947; 		1-231
2×CL; 6×MG; 2×O5I;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080297)
8aus
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×O3F;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080272)
8alr
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×MVU;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1075311)
8alt
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×MU9;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080267)
8aqz
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NF9;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-127
7nyg
 Heteromer
P31947; Q04206; 		1-231
2×UVT; 2×CL; 2×MG; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-122
7nzg
 Heteromer
P31947; Q04206; 		1-231
2×UWQ; 2×CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-069
7bjf
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×TZH;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1074359)
8anf
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×N1R;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080266)
8arq
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NKL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080299)
8b39
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×OT0;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-120
7nzv
 Heteromer
P31947; Q04206; 		1-231
2×UXN; 2×CL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1074202 - non covalent)
8av7
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O4I;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-111
7nr7
 Heteromer
P31947; Q04206; 		1-231
2×UON; 2×UOT; 2×PEG; 2×CL; 2×GOL;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (AZ210)
8byz
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×SD7;
Assess
Cys-42-tethered stabilizer 8 of 14-3-3(sigma)/ERa PPI
7ba6
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×T5Q;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-130
7ny4
 Heteromer
P31947; Q04206; 		1-231
2×UVN; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2046
7bg3
 Heteromer
P31947; Q13526; 		1-231
2×TKK; 2×CA; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-128
7nk3
 Heteromer
P31947; Q04206; 		1-231
2×UGQ; 2×CL; 2×CA; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-132
7njb
 Heteromer
P31947; Q04206; 		1-231
2×GOL; 2×CL; 2×UG8;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-142
7bjl
 Heteromer
P31947; Q04206; 		1-231
2×TWQ;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 6
8bjn
 Heteromer
P31947; P62508; 		1-231
6×MG; 2×CL; 2×QL9;
Assess
Small molecule stabilizer (1075481) for ERalpha and 14-3-3
8atp
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O0O;
Assess
Ternary structure of 14-3-3sigma, PKA-responsive ERa phosphopeptide and Fusicoccin-A
8c42
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×SIT;
Assess
Binary structure of 14-3-3s and RND3 phosphopeptide
8bfc
 Heteromer
P31947; P61587; 		1-231
8×MG; 2×CL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080265)
8ar5
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NJI;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-116
7o3p
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×CA; 2×GOL; 2×PEG; 2×V1K;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1080269)
8at9
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×NUO;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-134
7nye
 Heteromer
P31947; Q04206; 		1-231
2×UVH; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-119
7nla
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×CA; 2×UHT;
Assess
Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ162
7oqj
 Heteromer
P31947; Q4VCS5; 		1-231
6×09W; 2×CL;
Assess
14-3-3 sigma in complex with Pin1 binding site pS72 and covalently bound TCF521-026
7axn
 Heteromer
P31947; Q13526; 		1-231
2×S6B; 8×CA; 2×CL;
Assess
Crystal structure of 14-3-3 in complex with PyrinpS242 and a protein/peptide interface fragment
8c30
 Heteromer
O15553; P31947; 		1-231
2×463; 2×PE5; 2×MG; 2×CA;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 5
8b4q
 Heteromer
P31947; P62508; 		1-231
6×MG; 2×CL; 2×OYI;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2c-I with 14-3-3sigma
6faw
 Heteromer
P10636; P31947; 		1-231
2×CL; 1×MG; 2×NA; 2×D3K;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-131
7nyf
 Heteromer
P31947; Q04206; 		1-231
2×UVB; 2×MG; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-129
6yq2
 Heteromer
P31947; Q04206; 		1-231
2×P7T;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-118
7nle
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×GOL; 2×UHW;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-096
7o6o
 Heteromer
P31947; Q04206; 		1-231
2×V3Z; 2×CL; 2×CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-126
7nm1
 Heteromer
P31947; Q04206; 		1-231
2×UHN; 2×CA; 2×CL;
Assess
small molecule stabilizer for ERalpha and 14-3-3 (1083743)
8aq1
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NJC;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-154
7bjw
 Heteromer
P31947; Q04206; 		1-231
2×TZW;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-I with 14-3-3sigma
6fav
 Heteromer
P10636; P31947; 		1-231
5×NA; 2×D3Q; 2×CL;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1075478)
8aoy
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×N0L;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-123
6ypy
 Heteromer
P31947; Q04206; 		1-231
2×P7E;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-135
7nm3
 Heteromer
P31947; Q04206; 		1-231
2×UHQ; 4×GOL; 2×CA;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075302)
8c0k
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×SOI;
Assess
Ternary structure of 14-3-3s, RND3 phosphopeptide and dual-reactive compound 10
8b2k
 Heteromer
P31947; P61587; 		1-231
6×MG; 2×CL; 2×OQ3;
Assess
Binary structure of 14-3-3s and PKR phosphopeptide
8bi7
 Heteromer
P19525; P31947; 		1-231
8×MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-097
7o6m
 Heteromer
P31947; Q04206; 		1-231
2×V42; 2×CA; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-121
7nzk
 Heteromer
P31947; Q04206; 		1-231
2×UWK;
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide
3p1n
 Heteromer
P31947; Q9NPC2; 		1-231
6×MG; 2×CL;
Assess
Structure of 14-3-3 sigma in complex with PADI6 14-3-3 binding motif II
4dat
 Heteromer
P31947; Q6TGC4; 		1-231
2×MG;
Assess
Cys-42-tethered stabilizer 6 of 14-3-3(sigma)/ERa PPI
7ba3
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T5N;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-157
7o57
 Heteromer
P31947; Q04206; 		1-231
2×V2E;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-125
7nz6
 Heteromer
P31947; Q04206; 		1-231
2×UWH; 2×CA; 2×CL; 4×GOL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 126B with 14-3-3sigma
4y5i
 Heteromer
P10636; P31947; 		1-231
2×CL;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 8
8bjg
 Heteromer
P31947; P62508; 		1-231
8×MG; 2×CL; 2×QL0;
Assess
Small molecule amidine soak in 14-3-3/ERa (AZ037)
8c4f
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×TG9;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-117
7o3f
 Heteromer
P31947; Q04206; 		1-231
2×V0W; 2×CL; 2×MG; 6×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-080
7o6k
 Heteromer
P31947; Q04206; 		1-231
2×V4N; 2×CL; 2×CA; 2×GOL;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 09
7nnd
 Heteromer
P31947; Q4VCS5; 		1-231
2×CL; 2×MG; 2×K7N;
Assess
14-3-3 Sigma in complex with phosphorylated MLF1 peptide
6y8e
 Heteromer
P31947; P58340; 		1-231
4×CA; 4×MG; 2×CL;
Assess
Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ178
7oq8
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×CL; 4×0B7;
Assess
Cys-42-tethered stabilizer 7 of 14-3-3(sigma)/ERa PPI
7ba5
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T5T;
Assess
Cys-42-tethered stabilizer 9 of 14-3-3(sigma)/ERa PPI
7ba7
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T5W;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-II with 14-3-3sigma
6fbw
 Heteromer
P10636; P31947; 		1-231
2×CL; 4×NA; 2×D4K;
Assess
A novel phospho-switch in the linker region of the snail zinc finger protein which regulates 14-3-3…
4qli
 Heteromer
O95863; P31947; 		1-231
4×MG; 2×GOL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080273)
8ary
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NQU;
Assess
Crystal structure of 14-3-3 sigma in complex with Shroom3 P1244L
6fcp
 Heteromer
P31947; Q8TF72; 		1-231
4×MG; 4×CL;
Assess
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910
5myc
 Heteromer
P31947; Q5S007; 		1-231
4×CA; 2×CL; 2×NA;
Assess
Small molecule amidine soak in 14-3-3/ERa (AZ132)
8c4g
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×KM8;
Assess
Fragment AZ-010 binding at the p53pT387/14-3-3 sigma interface
6rwu
 Heteromer
P04637; P31947; 		1-231
2×KM8;
Assess
14-3-3sigma in complex with a A130beta3A mutated YAP pS127 phosphopeptide
6g8j
 Heteromer
P31947; P46937; 		1-231
2×CL; 2×MG; 2×NA;
Assess
Cys-42-tethered stabilizer 11 of 14-3-3(sigma)/ERa PPI
7ba9
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×T6N;
Assess
Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide and ligands Fusicoccin-A a…
7niz
 Heteromer
P03372; P31947; 		1-231
2×FSC; 2×UGH;
Assess
14-3-3 Sigma in complex with phosphorylated c-Jun peptide
6y3v
 Heteromer
P05412; P31947; 		1-231
4×MG; 4×CA;
Assess
small molecule stabilizer (compound 1) for C-RAF pS259 and 14-3-3
8av0
 Heteromer
P04049; P31947; 		1-231
2×CL; 6×MG; 2×O6C;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1076406)
8arz
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NQ0;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076397)
8am7
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×MRF;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080294)
8aqc
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×NIB;
Assess
Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ136
7oqg
 Heteromer
P31947; Q4VCS5; 		1-231
6×0AW; 2×BME; 2×MG;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076405)
8arg
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×ND9;
Assess
14-3-3 sigma in complex with Pin1 binding site pS72
7aog
 Heteromer
P31947; Q13526; 		1-231
4×CA; 4×CL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2b with 14-3-3sigma
6fby
 Heteromer
P10636; P31947; 		1-231
2×CL; 4×NA; 2×D4H;
Assess
14-3-3 Sigma in complex with phosphorylated CAMKK2 peptide
6y3o
 Heteromer
P31947; Q96RR4; 		1-231
4×MG; 2×CA;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076398)
8as1
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×NQL;
Assess
14-3-3 Sigma in complex with phosphorylated camkk2{pS511} peptide
6y8a
 Heteromer
P31947; Q96RR4; 		1-231
6×MG; 2×CL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1075310)
8alw
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×MVO;
Assess
14-3-3 Sigma in complex with phosphorylated (Thr391) Gab2 peptide
6y3r
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080300)
8ar4
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NG9;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 40
7nmw
 Heteromer
P31947; Q4VCS5; 		1-231
2×UJW; 2×CL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076402)
8arw
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NQ9;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1080298)
8auy
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O2X;
Assess
14-3-3 Sigma in complex with phosphorylated caspase{pS164} peptide
6y8d
 Heteromer
P31947; P42575; 		1-231
8×MG; 2×CL;
Assess
14-3-3sigma in complex with SLP76pS376 phosphopeptide crystal structure
6zcj
 Heteromer
P31947; Q13094; 		1-231
10×MG;
Assess
Fragment AZ-009 binding at the p53pT387/14-3-3 sigma interface
6rws
 Heteromer
P04637; P31947; 		1-231
2×KLZ; 2×MG;
Assess
FC-J acetonide stabilizer of 14-3-3 and ERalpha
8bzf
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×SJ4;
Assess
14-3-3 Sigma in complex with phosphorylated caspase{pS139} peptide
6y8b
 Heteromer
P31947; P42575; 		1-231
6×MG; 2×CL;
Assess
Fragment AZ-015 binding at the p53pT387/14-3-3 sigma interface
6rjz
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×GOL; 2×K6B;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1005
7nj6
 Heteromer
P31947; Q13526; 		1-231
2×UG5; 2×CA;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1076403)
8alv
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×MV3;
Assess
14-3-3sigma in complex with a R124beta3R mutated YAP pS127 phosphopeptide
6g8i
 Heteromer
P31947; P46937; 		1-231
2×CL; 2×MG; 4×NA;
Assess
Small molecule stabilizer (compound 5) for C-RAF(pS259) and 14-3-3
8a68
 Heteromer
P04049; P31947; 		1-231
6×MG; 2×L7U;
Assess
14-3-3 in complex with PyrinpS208pS242
8c28
 Heteromer
O15553; P31947; 		1-231
1×B3P;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound CV1040
8c2g
 Heteromer
P31947; Q13526; 		1-231
2×T85; 4×MG;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080295)
8aqe
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×NE9;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1075297)
8axu
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O6L;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074398)
8byb
 Heteromer
P03372; P31947; 		1-231
2×S8O;
Assess
Fragment-linked stabilizer for ERa - 14-3-3 interaction (1075293)
8bxs
 Heteromer
P03372; P31947; 		1-231
2×S2E;
Assess
Fragment AZ-026 binding at the p53pT387/14-3-3 sigma interface
6rm7
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×K92;
Assess
Fragment-linked stabilizer for 14-3-3 and ERa (1075298)
8bwx
 Heteromer
P03372; P31947; 		1-231
2×RZT;
Assess
Small molecular stabilizer for ERalpha and 14-3-3sigma (1080268)
8ai0
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×M79;
Assess
Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ162
7oq7
 Heteromer
P03372; P31947; 		1-231
4×09W; 2×BME; 2×CL; 4×MG;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074393)
8bwz
 Heteromer
P03372; P31947; 		1-231
2×S3I;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074392)
8bx4
 Heteromer
P03372; P31947; 		1-231
2×RZC;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1075305)
8av4
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O49;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075316)
8byc
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×S7R;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075296)
8bxq
 Heteromer
P03372; P31947; 		1-231
2×S3U;
Assess
Small molecule stabilizer (compound 8) for C-RAF and 14-3-3
8a6f
 Heteromer
P04049; P31947; 		1-231
2×CL; 4×MG; 2×O56;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074395)
8byy
 Heteromer
P03372; P31947; 		1-231
2×SE3;
Assess
Fragment AZ-025 binding at the p53pT387/14-3-3 sigma interface
6rl4
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×K7N;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080291)
8aro
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×NJR;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075313)
8bye
 Heteromer
P03372; P31947; 		1-231
2×RY0;
Assess
14-3-3 sigma with Pin1 binding site pS72 and bound Fusicoccin A
8c3c
 Heteromer
P31947; Q13526; 		1-231
2×FSC; 2×MG;
Assess
Small molecule stabilizer (compound 7) for C-RAF and 14-3-3
8a6h
 Heteromer
P04049; P31947; 		1-231
2×CL; 4×MG; 2×L6L;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074399)
8bxn
 Heteromer
P03372; P31947; 		1-231
2×S1R;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075287)
8bxo
 Heteromer
P03372; P31947; 		1-231
2×S1I;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1080293)
8au2
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O3O;
Assess
Fragment AZ-024 binding at the p53pT387/14-3-3 sigma interface
6rl6
 Heteromer
P04637; P31947; 		1-231
2×MG; 2×CL; 2×K7Q;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074386)
8bwj
 Heteromer
P03372; P31947; 		1-231
2×RYR;
Assess
Small molecule stabilizer (compound 3) for FOXO1 and 14-3-3
8a65
 Heteromer
P31947; Q12778; 		1-231
4×MG; 2×L70;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074397)
8bxm
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×S0U;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interactions (1075288)
8byd
 Heteromer
P03372; P31947; 		1-231
2×S7I;
Assess
Small molecule stabilizer (compound 2) for FOXO1 and 14-3-3
8a62
 Heteromer
P31947; Q12778; 		1-231
4×MG; 2×L7L;
Assess
14-3-3 sigma in complex with SMAD4 pS403 peptide
6yic
 Heteromer
P31947; Q13485; 		1-231
2×GOL; 4×NA; 4×MG; 2×CA;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1074388)
8bx0
 Heteromer
P03372; P31947; 		1-231
2×S2U;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1075292)
8by9
 Heteromer
P03372; P31947; 		1-231
2×S86;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1075306)
8aze
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O5I;
Assess
14-3-3 sigma bound to canonical mono-phosphorylated aminopeptidase N (APN, CD13) binding motif
6xwd
 Heteromer
P15144; P31947; 		1-231
4×NA; 2×CA; 4×MG;
Assess
Fragment AZ-011 binding at the p53pT387/14-3-3 sigma interface
6sip
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×LFB;
Assess
Fragment AZ-012 binding at the p53pT387/14-3-3 sigma interface
6siq
 Heteromer
P04637; P31947; 		1-231
2×CL; 4×LF5;
Assess
Fragment AZ-014 binding at the p53pT387/14-3-3 sigma interface
6rk8
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×K6N;
Assess
Fragment AZ-017 binding at the p53pT387/14-3-3 sigma interface
6sio
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 4×LFQ;
Assess
Crystal structure of 14-3-3sigma in complex with a PAK6 pT99 phosphopeptide
6qdr
 Heteromer
P31947; Q9NQU5; 		1-231
4×CA; 2×CL; 2×MG; 6×NA;
Assess
Fragment AZ-020 binding at the p53pT387/14-3-3 sigma interface
6sin
 Heteromer
P04637; P31947; 		1-231
2×K65;
Assess
14-3-3 sigma sirtuin-1 phospho-peptide complex
8anb
 Heteromer
P31947; Q96EB6; 		1-231
2×MG; 2×CL;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide and stabilizer fu…
3p1s
 Heteromer
P31947; Q9NPC2; 		1-231
2×FSC; 2×CL; 4×MG;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1047455)
8byf
 Heteromer
P03372; P31947; 		1-231
2×S6X;
Assess
Fragment AZ-002 binding at the p53pT387/14-3-3 sigma interface
6rwi
 Heteromer
P04637; P31947; 		1-231
2×KLE; 2×CA; 4×MG;
Assess
Fragment AZ-007 binding at a primary and secondary binding site of the the p53pT387/14-3-3 sigma co…
6rwh
 Heteromer
P04637; P31947; 		1-231
4×KLB; 2×CA; 4×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1012
7bgv
 Heteromer
P31947; Q13526; 		1-231
2×TLK; 2×CA; 2×CL; 2×MG;
Assess
Fragment AZ-004 binding at a primary and secondary site in a p53pT387/14-3-3 complex
6s9q
 Heteromer
P04637; P31947; 		1-231
6×L1T; 2×CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-110
7nm9
 Heteromer
P31947; Q04206; 		1-231
2×S9E; 2×PEG;
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS324
5btv
 Heteromer
P10636; P31947; 		1-231
4×MG; 2×CA; 2×CL;
Assess
14-3-3 isoform sigma in complex with a phosphorylated C-RAF peptide
4iea
 Heteromer
P04049; P31947; 		1-231
Assess
14-3-3 sigma in complex with SMAD3 pS423 peptide
6yib
 Heteromer
P31947; P84022; 		1-231
6×MG; 6×CL; 2×CA; 2×GOL; 2×NA;
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…
6hkb
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×G8Q;
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide
3p1r
 Heteromer
P31947; Q9NPC2; 		1-231
8×MG; 8×CL; 2×CA;
Assess
Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075297)
8atr
 Heteromer
P04049; P31947; 		1-231
2×CL; 4×MG; 2×O6L;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 109B with 14-3-3sigma
4y32
 Heteromer
P10636; P31947; 		1-231
1×49F;
Assess
co-soak stabilizers for ERa - 14-3-3 interaction (884_AZ275)
8bzb
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×GEH; 2×SH9;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2d with 14-3-3sigma
6fi5
 Heteromer
P10636; P31947; 		1-231
2×CL; 2×MG; 8×NA; 2×60H;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 Peptide and stabilizer fu…
3p1q
 Heteromer
P31947; Q9NPC2; 		1-231
2×FSC; 2×CL; 4×MG; 2×CA;
Assess
Cys-45-tethered stabilizer 3 of 14-3-3(sigma)/ERa PPI
7b9m
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×T4W;
Assess
Ternary complex of 14-3-3 sigma, Usp8pS718 phosphopeptide and small molecule stabilizer
8adm
 Heteromer
P31947; P40818; 		1-231
2×O6C;
Assess
fragment-linked stabilizer for ERa - 14-3-3 interaction (1047648)
8byg
 Heteromer
P03372; P31947; 		1-231
2×S6O;
Assess
Crystal structure of 14-3-3sigma in complex with a RapGef2 pT740 phosphopeptide
6qdt
 Heteromer
P31947; Q9Y4G8; 		1-231
2×CA; 2×CL; 10×NA;
Assess
14-3-3 Sigma in complex with phosphorylated SOS1 peptide
6y44
 Heteromer
P31947; Q07889; 		1-231
6×MG; 8×CL; 2×CA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound TCF521-011
7nif
 Heteromer
P31947; Q13526; 		1-231
2×P5N; 4×CA; 2×CL;
Assess
Crystal structure of 14-3-3sigma in complex with a PAK6 pT99 phosphopeptide stabilized by semi-synt…
6qds
 Heteromer
P31947; Q9NQU5; 		1-231
2×HY5; 2×CL; 4×NA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1017
7bdp
 Heteromer
P31947; Q13526; 		1-231
2×TJB; 2×MG;
Assess
14-3-3 sigma in complex with hDM2-186 peptide
6yr6
 Heteromer
P31947; Q00987; 		1-231
6×IOD;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1006
7nja
 Heteromer
P31947; Q13526; 		1-231
2×UG2; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1019
7bgq
 Heteromer
P31947; Q13526; 		1-231
2×TL8; 6×CA; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide
7nma
 Heteromer
P31947; Q4VCS5; 		1-231
2×CL; 2×MG;
Assess
14-3-3 Sigma in complex with phosphorylated PLN peptide
6y40
 Heteromer
P26678; P31947; 		1-231
6×MG; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1002F1
7nrk
 Heteromer
P31947; Q13526; 		1-231
2×UPQ; 2×CA; 2×CL; 4×PEG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1009
7bdt
 Heteromer
P31947; Q13526; 		1-231
2×TJ8; 2×MG;
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilizer Fusicoccin H
3ux0
 Heteromer
P31947; Q9NPC2; 		1-231
8×MG; 2×CL; 2×GOL; 2×0DV;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound TCF521-110
7ayf
 Heteromer
P31947; Q13526; 		1-231
2×S9E; 2×CA;
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Co…
3sp5
 Heteromer
P31947; Q9NPC2; 		1-231
2×CX7; 4×MG;
Assess
Ternary complex of 14-3-3 sigma, Pin1pS72 phosphopeptide, and WQ162
7oqa
 Heteromer
P31947; Q13526; 		1-231
4×09W; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with PKR phosphopeptide and stabilizer Fusicoccin-A
7obl
 Heteromer
P19525; P31947; 		1-231
2×FSC; 4×MG;
Assess
Ternary complex of 14-3-3 sigma, p27pT198 phosphopeptide, and WQ147
7ors
 Heteromer
P31947; P46527; 		1-231
6×MG; 2×CL; 2×0I2;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-176
7o6g
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V4H; 2×CA; 2×PEG; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-164
7o5g
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V3B; 4×PEG; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1016
7bgr
 Heteromer
P31947; Q13526; 		1-231
2×TQK; 2×CA; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with LDB1 phosphopeptide
7ob5
 Heteromer
P31947; Q86U70; 		1-231
4×CA; 2×CL; 2×MG; 2×GOL;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1075299)
8av3
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O3T;
Assess
Ternary complex of 14-3-3 sigma, NotchpS1917 phosphopeptide, and WQ136
7or3
 Heteromer
P31947; Q99466; 		1-231
2×CL; 2×MG; 6×0AW;
Assess
Ternary complex of 14-3-3 sigma, NotchpS1917 phosphopeptide, and WQ178
7or7
 Heteromer
P31947; Q99466; 		1-231
2×CL; 2×MG; 2×0B7;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma
5hf3
 Heteromer
P10636; P31947; 		1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-044
7bjb
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×TZK; 2×GOL; 4×CA; 2×MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-158
7o5a
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×V2Q;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-033
6yp8
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×P6Z;
Assess
Ternary complex of 14-3-3 sigma, p27pT198 phosphopeptide, and WQ162
7org
 Heteromer
P31947; P46527; 		1-231
4×09W; 4×MG; 2×CL;
Assess
Ternary complex of 14-3-3 sigma, NotchpS1917 phosphopeptide, and WQ162
7or5
 Heteromer
P31947; Q99466; 		1-231
2×CL; 2×09W;
Assess
Ternary complex of 14-3-3 sigma, p27pT198 phosphopeptide, and WQ178
7orh
 Heteromer
P31947; P46527; 		1-231
4×0B7; 4×MG; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-037
6ypl
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×P6H;
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Fu…
3smo
 Heteromer
P31947; Q9NPC2; 		1-231
2×FJA; 6×MG;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma
4y3b
 Heteromer
P10636; P31947; 		1-231
1×49F;
Assess
Ternary complex of 14-3-3 sigma, Pin1pS72 phosphopeptide, and WQ136
7oq9
 Heteromer
P31947; Q13526; 		1-231
6×0AW; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-168
7o5u
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V3T; 2×CA;
Assess
Crystal structure of 14-3-3 sigma in complex with LDB1 phosphopeptide and stabilizer Fusicoccin-A
7ob8
 Heteromer
P31947; Q86U70; 		1-231
2×FSC; 2×CL; 4×MG;
Assess
Crystal structure of 14-3-3 sigma in complex with NPM1 phosphopeptide
7obg
 Heteromer
P06748; P31947; 		1-231
2×CL; 6×MG;
Assess
Small molecule stabilizer for ERalpha and 14-3-3 (1074210)
8axe
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×ODC;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1032
7nrl
 Heteromer
P31947; Q13526; 		1-231
6×UPK; 4×GOL; 4×PEG; 2×MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-041
7o3q
 Heteromer
P31947; Q04206; 		1-231
6×CL; 2×V1Q; 2×PEG;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 41
7nn2
 Heteromer
P31947; Q4VCS5; 		1-231
2×K8W; 2×CA; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-167
7o5s
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V3Q; 2×MG; 2×GOL;
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide
7obs
 Heteromer
O43353; P31947; 		1-231
2×CA; 6×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2068A
7bfw
 Heteromer
P31947; Q13526; 		1-231
2×TKH; 2×CA; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-175
7biy
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×TWE;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-173
7o5x
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V3W; 2×CA; 2×PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-011
6yp2
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×P5N;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-160
7o5d
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V2W; 2×MG; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-165
7o5o
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V3K; 2×GOL; 2×CA;
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV2
5n5t
 Heteromer
P31947; Q9GZV5; 		1-231
4×MG; 2×CL; 2×8OB;
Assess
Small molecular stabilizer for ERalpha and 14-3-3 (1075300)
8av8
 Heteromer
P03372; P31947; 		1-231
4×MG; 2×O4R;
Assess
Ternary complex of 14-3-3 sigma, p27pT198 phosphopeptide, and WQ136
7or8
 Heteromer
P31947; P46527; 		1-231
6×0AW; 4×MG; 2×CL; 2×CA;
Assess
small molecule stabilizer for ERalpha and 14-3-3 (1074202)
8awg
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×O4I;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-025
6yoy
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×L3S;
Assess
Crystal structure of 14-3-3 sigma in complex with SSBP4 phosphopeptide
7obx
 Heteromer
P31947; Q9BWG4; 		1-231
4×MG; 2×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-028
6yp3
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×P5Q;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-042
7o3r
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V1E; 2×CA; 2×GOL;
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide
5moc
 Heteromer
P04637; P31947; 		1-231
2×CL; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1007
7nj8
 Heteromer
P31947; Q13526; 		1-231
2×JFS; 2×CA; 2×MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-085
7o6i
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V4B; 2×CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-161
7o5f
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V32; 2×MG; 2×PEG;
Assess
Crystal structure of 14-3-3 sigma in complex with PKR phosphopeptide
7obk
 Heteromer
P19525; P31947; 		1-231
4×MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-159
7o5c
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×V2T; 2×GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-166
7o5p
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×V3N;
Assess
Fragment AZ-010 binding at the TAZpS89/14-3-3 sigma interface
6slx
 Heteromer
P31947; Q9GZV5; 		1-231
2×KM8;
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…
6hkf
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×G8T;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2068B
7bdy
 Heteromer
P31947; Q13526; 		1-231
2×TJK; 2×CA; 2×CL; 2×MG;
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV1
5n5r
 Heteromer
P31947; Q9GZV5; 		1-231
6×MG; 2×CL; 2×NV1;
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…
6hhp
 Heteromer
P03372; P31947; 		1-231
6×MG; 2×G4Z;
Assess
Crystal structure of 14-3-3 sigma in complex with Ataxin-1 Ser776 phosphopeptide
6qiu
 Heteromer
P31947; P54253; 		1-231
2×MG; 2×CL;
Assess
14-3-3 sigma in complex with TAZ pS89 peptide
5n75
 Heteromer
P31947; Q9GZV5; 		1-231
6×MG; 6×CL;
Assess
Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ136
7opw
 Heteromer
P03372; P31947; 		1-231
6×0AW; 4×MG; 2×CL; 2×BME;
Assess
Fragment AZ-005 binding at the p53pT387/14-3-3 sigma interface
6rx2
 Heteromer
P04637; P31947; 		1-231
6×MG; 2×CA; 2×KM2;
Assess
Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st…
6tjm
 Heteromer
P03372; P31947; 		1-231
4×MG; 4×NE5;
Assess
14-3-3sigma in complex with a A130beta3A and Q133beta3Q mutated YAP pS127 phosphopeptide
6g8q
 Heteromer
P31947; P46937; 		1-231
2×CA; 4×CL; 6×NA;
Assess
Fragment AZ-018 binding at the p53pT387/14-3-3 sigma interface
6s39
 Heteromer
P04637; P31947; 		1-231
2×K5Z; 2×CA;
Assess
Fragment AZ-022 binding at the p53pT387/14-3-3 sigma interface
6rkm
 Heteromer
P04637; P31947; 		1-231
2×MG; 2×CL; 2×GOL; 4×K6Z;
Assess
Fragment AZ-021 binding at the p53pT387/14-3-3 sigma interface
6rkk
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×GOL; 2×K6W;
Assess
Fragment AZ-023 binding at the p53pT387/14-3-3 sigma interface
6rki
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×K6T;
Assess
14-3-3sigma in complex with BLNKpT152 phosphopeptide crystal structure
6ylu
 Heteromer
P31947; Q8WV28; 		1-231
6×MG;
Assess
Fragment AZ-016 binding at the p53pT387/14-3-3 sigma interface
6rm5
 Heteromer
P04637; P31947; 		1-231
6×MG; 2×CL; 4×K8W;
Assess
Fragment AZ-006 binding at the p53pT387/14-3-3 sigma interface
6r5l
 Heteromer
P04637; P31947; 		1-231
4×MG; 2×CL; 2×GOL; 2×JT2;
Assess
Fragment AZ-019 binding at the TAZpS89/14-3-3 sigma interface
6rp6
 Heteromer
P31947; Q9GZV5; 		1-231
2×KDK; 2×CA; 2×NA;
Assess
Fragment AZ-006 binding at the TAZpS89/14-3-3 sigma interface
6rjq
 Heteromer
P31947; Q9GZV5; 		1-231
4×JT2;
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214
4fl5
 Heteromer
P10636; P31947; 		1-231
2×CL; 4×MG; 6×CA; 3×GOL;
Assess
Fragment AZ-013 binding at the p53pT387/14-3-3 sigma interface
6slv
 Heteromer
P04637; P31947; 		1-231
6×MG; 2×CL; 2×LJW;
Assess
14-3-3 sigma in complex with FOXO1 pS256 peptide
6qzs
 Heteromer
P31947; Q12778; 		1-231
2×GOL; 1×B3P;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide and stabilizer Fu…
3sml
 Heteromer
P31947; Q9NPC2; 		1-231
2×FW1; 2×CL; 8×MG;
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilisator Fusicoccin A
3p1o
 Heteromer
P31947; Q9NPC2; 		1-231
2×FSC; 2×CL; 2×CA; 8×MG;
Assess
Fragment AZ-001 binding at the p53pT387/14-3-3 sigma interface and additional sites
6s40
 Heteromer
P04637; P31947; 		1-231
8×MG; 2×CL; 8×KTW; 2×GOL; 2×CA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1011
7bgw
 Heteromer
P31947; Q13526; 		1-231
2×TLQ; 4×CA; 2×CL; 2×NA;
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilizer 16-O-Me-FC-H
4fr3
 Heteromer
P31947; Q9NPC2; 		1-231
2×0V4; 4×MG;
Assess
Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ178
7oqw
 Heteromer
P31947; Q4VCS5; 		1-231
4×0B7; 4×MG;
Assess
14-3-3 sigma with AS160 binding site pT642
7nix
 Heteromer
O60343; P31947; 		1-231
4×NHE; 4×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1008
7nig
 Heteromer
P31947; Q13526; 		1-231
2×UFH; 4×CA; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with Phosphorylated and Farnesylated Rnd3 peptide
7obc
 Heteromer
P31947; P61587; 		1-231
2×CL; 2×MG; 2×FAR;
Assess
14-3-3sigma in complex with a P129beta3P and L132beta3L mutated YAP pS127 phosphopeptide
6g8p
 Heteromer
P31947; P46937; 		1-231
4×CA; 2×CL;
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (LBD) phosphopeptide
6y58
 Heteromer
P31947; P62508; 		1-231
6×MG;
Assess
14-3-3sigma in complex with a TASK3 peptide stabilized by semi-synthetic natural product FC-NAc
6ghp
 Heteromer
P31947; Q9NPC2; 		1-231
2×EZ5; 2×CL; 4×NA;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide
3p1p
 Heteromer
P31947; Q9NPC2; 		1-231
2×CL; 6×MG;
Assess
14-3-3 Sigma in complex with phosphorylated (pS210) Gab2 peptide
6y3s
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 22
7nne
 Heteromer
P31947; Q4VCS5; 		1-231
2×K92; 2×CL;
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer FC…
3spr
 Heteromer
P31947; Q9NPC2; 		1-231
2×FC7; 2×CL; 6×MG;
Assess
Crystal structure of 14-3-3 sigma in complex with NPM1 phosphopeptide and stabilizer Fusicoccin-A
7obh
 Heteromer
P06748; P31947; 		1-231
2×FSC; 2×CL;
Assess
Structure of 14-3-3 isoform sigma in complex with a C-Raf1 peptide and a stabilizing small molecule…
3o8i
 Heteromer
P04049; P31947; 		1-231
2×M1T;
Assess
Crystal structure of 14-3-3 sigma in complex with Phosphorylated and Farnesylated Rnd3 peptide and …
7obd
 Heteromer
P31947; P61587; 		1-231
2×FSC; 4×MG; 2×CL; 2×FAR;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with task-3 peptide and stabilizer Fu…
3smn
 Heteromer
P31947; Q9NPC2; 		1-231
2×FC7; 4×MG; 4×CA; 4×CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-178
7o6f
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V4K; 2×CA; 2×GOL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma
6fi4
 Heteromer
P10636; P31947; 		1-231
2×CA; 2×CL; 2×NA; 2×60H;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-045
7o3s
 Heteromer
P31947; Q04206; 		1-231
4×CL; 2×V1H; 2×MG;
Assess
Structure of 14-3-3 sigma in complex with PADI6 14-3-3 binding motif I
4dau
 Heteromer
P31947; Q6TGC4; 		1-231
Assess
Fragment AZ-019 binding at the p53pT387/14-3-3 sigma interface
6s3c
 Heteromer
P04637; P31947; 		1-231
2×MG; 2×CL; 2×GOL; 2×KDK;
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with task-3 peptide and stabilizer Fu…
3smm
 Heteromer
P31947; Q9NPC2; 		1-231
2×FJA; 6×MG; 2×CL;
Assess
Fragment AZ-004 binding at the TAZpS89/14-3-3 sigma interface
6slw
 Heteromer
P31947; Q9GZV5; 		1-231
4×L1T;
Assess
SARS-CoV-2 Nucleocapsid phosphopeptide 193-200 bound to human 14-3-3 sigma
7qik
 Heteromer
P0DTC9; P31947; 		1-231
4×PEG; 2×GOL; 4×BR; 1×TRS;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-027
6yox
 Heteromer
P31947; Q04206; 		1-231
2×CL; 2×L3V; 2×CA; 2×MG;
Assess
14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface
4jc3
 Heteromer
P03372; P31947; 		1-231
6×MG;
Assess
14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface
4jdd
 Heteromer
P03372; P31947; 		1-231
2×FSC;
Assess
Crystal structure of 14-3-3 sigma in complex with SSBP4 phosphopeptide and stabilizer Fusicoccin-A
7oby
 Heteromer
P31947; Q9BWG4; 		1-231
2×FSC; 2×CL; 4×MG;
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Co…
3smk
 Heteromer
P31947; Q9NPC2; 		1-231
2×CW7; 2×MG;
Assess
14-3-3 sigma in complex with hDMX-342+367 peptide
6yr7
 Heteromer
O15151; P31947; 		1-231
1×B3P;
Assess
14-3-3 sigma in complex with hDMX-367 peptide
6yr5
 Heteromer
O15151; P31947; 		1-231
1×SO4;
Assess
14-3-3 sigma in complex with FOXO1 pT24 peptide
6qzr
 Heteromer
P31947; Q12778; 		1-231
1×B3P; 2×GOL;
Assess
Henipavirus W protein interacts with 14-3-3 to modulate host gene expression
6w0l
 Heteromer
P0C1C7; P31947; 		1-231
2×CA;
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide and stabilizer Fusicoccin-A
7obt
 Heteromer
O43353; P31947; 		1-231
2×FSC; 4×MG; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 12
7nmx
 Heteromer
P31947; Q4VCS5; 		1-231
2×K7Q; 4×CA; 6×CL; 2×MG;
Assess
Structure of 14-3-3 sigma delta C with electrophilic peptide 3MHR-5
8c2f
 Heteromer
P31947; P46937; 		1-231
2×TJI; 2×MG; 6×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with a C-terminal Estrogen Receptor alpha phosphopepti…
7pwt
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×PJN;
Assess
Ternary complex of 14-3-3 sigma, p27pT198 phosphopeptide, and WQ176
7ort
 Heteromer
P31947; P46527; 		1-231
2×0HP; 4×MG; 2×CL;
Assess
Human 14-3-3 sigma CLU3 mutant complexed with short HSPB6 phosphopeptide
5lu1
 Heteromer
O14558; P31947; 		1-231
2×TRS;
Assess
Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st…
6tl3
 Heteromer
P03372; P31947; 		1-231
2×NJW;
Assess
Crystal structure of 14-3-3 sigma in complex with a C-terminal Estrogen Receptoralpha phosphopeptid…
7pwz
 Heteromer
P03372; P31947; 		1-231
2×MG; 2×8CQ;
Assess
14-3-3 Sigma in complex with phosphorylated Gab2pT391 peptide - 96h incubation
6zvd
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
Engineered conjugation of lysine-specific molecular tweezers with ExoS derived peptidic inhibitor e…
6y7t
 Heteromer
G3XDA1; P31947; 		1-231
1×TWZ; 3×NA; 1×GOL;
Assess
14-3-3 Sigma in complex with phosphorylated Gab2pT391 peptide - 24h incubation
6zvb
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
14-3-3 Sigma in complex with phosphorylated Gab2pT391 peptide - 48h incubation
6zvc
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
14-3-3 Sigma in complex with phosphorylated Gab2pT391 peptide - 1h incubation
6zve
 Heteromer
P31947; Q9UQC2; 		1-231
4×MG;
Assess
Human 14-3-3 sigma fused to the StARD1 peptide including phosphoserine-195
6t5f
 Heteromer
P31947; P49675; 		1-231
Assess
SARS-CoV-2 Nucleocapsid phosphopeptide 201-210 bound to human 14-3-3 sigma
7qip
 Heteromer
P0DTC9; P31947; 		1-231
3×CL;
Assess
Human 14-3-3 sigma fused to the AANAT peptide including phosphoserine-205
6t80
 Heteromer
P31947; Q16613; 		1-231
Assess
CH2 chimera of human 14-3-3 sigma with the Gli1 phosphopeptide around Ser640
5om0
 Heteromer
P08151; P31947; 		1-231
4×SO4; 2×TRS;
Assess
CH3 chimera of human 14-3-3 sigma with the StARD1 peptide including Ser57
5oma
 Heteromer
P31947; P49675; 		1-231
1×TRS; 1×SO4;
Assess
Complex of human 14-3-3 sigma CLU1 mutant with phosphorylated heat shock protein B6
5ltw
 Heteromer
O14558; P31947; 		1-231
2×TRS; 1×NI;
Assess
GBP1 bound by 14-3-3sigma
8q4l
 Heteromer
P31947; P32455; 		1-231
Assess
Human 14-3-3 sigma complexed with long HSPB6 phosphopeptide
5lu2
 Heteromer
O14558; P31947; 		2-231
Assess
CH1 chimera of human 14-3-3 sigma with the HSPB6 phosphopeptide in a conformation with swapped phos…
5ok9
homo-4-mer1-231
5×PEG;
Assess
The crystal structure of 14-3-3-sigma at 2.8 angstrom resolution
1yz5
homo-2-mer1-233
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…
6hmt
homo-2-mer1-231
2×MG; 2×GEH;
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide stabilized by…
5mxo
homo-2-mer1-231
2×FSC; 2×CL; 2×MG;
Assess
14-3-3sigma in complex with SHN3pS542 phosphopeptide crystal structure
7b13
homo-2-mer1-231
8×MG;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhr
homo-2-mer1-231
10×MG; 4×CL; 2×GOL; 2×Y04;
Assess
14-3-3sigma bound to strep-tagged PKA-responsive ERa phosphopeptide
8c3z
homo-2-mer1-231
8×MG;
Assess
Ternary structure of 14-3-3sigma, strep-tagged PKA-responsive ERa phosphopeptide, and Fusicoccin-A.
8c43
homo-2-mer1-231
6×MG; 2×SIT;
Assess
14-3-3sigma bound to PKA-responsive ERa phosphopeptide
8c40
homo-2-mer1-231
8×MG;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 4
8b2i
homo-2-mer1-231
6×MG; 2×CL; 2×OQ9;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 10
8b5p
homo-2-mer1-231
4×MG; 2×CL; 2×OQ3;
Assess
14-3-3 in complex with Pyrinp pS242
8c2y
homo-2-mer1-231
Assess
14-3-3 Sigma in complex with phosphorylated ATPase peptide
6y3m
homo-2-mer1-231
6×MG; 2×CA;
Assess
14-3-3sigma in complex with SHN3pT869 phosphopeptide crystal structure
7b15
homo-2-mer1-231
8×MG;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
3t0l
homo-2-mer1-231
2×1CT; 4×GOL; 6×CL; 4×MG;
Assess
14-3-3s binding to non-natural peptide 2d
7zmu
homo-2-mer1-231
4×MG;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
3t0m
homo-2-mer1-231
2×2CT; 4×GOL; 4×CL; 6×MG;
Assess
Crystal structure of 14-3-3sigma in complex with a RapGef2 pT740 phosphopeptide inhibited by semi-s…
6qdu
homo-2-mer1-231
2×HY5; 2×TPO; 2×CL; 4×NA;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhu
homo-2-mer1-231
10×MG; 4×CL; 2×GOL; 2×0KH;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dho
homo-2-mer1-231
8×MG; 4×CL; 2×GOL; 2×Y09;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhm
homo-2-mer1-231
6×MG; 6×CL; 2×GOL; 2×0KB;
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…
6hn2
homo-2-mer1-231
4×MG; 2×GF8;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhs
homo-2-mer1-231
6×MG; 4×CL; 2×GOL; 2×Y03;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhp
homo-2-mer1-231
10×MG; 4×CL; 2×GOL; 2×Y07;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhq
homo-2-mer1-231
10×MG; 4×CL; 2×GOL; 2×Y06;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dht
homo-2-mer1-231
4×MG; 4×CL; 2×GOL; 2×0KG;
Assess
Small-molecule inhibitor of 14-3-3 protein-protein interactions
6ye9
homo-2-mer1-231
6×MG; 2×OO8;
Assess
Crystal structure of 14-3-3 sigma in complex with CIP2ApS904 peptide
7bm9
homo-2-mer1-231
2×CL; 4×MG;
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening
4dhn
homo-2-mer1-231
6×MG; 4×CL; 2×GOL; 2×0KC;
Assess
Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins
3u9x
homo-2-mer1-231
4×MG; 6×CL; 2×GOL;
Assess
14-3-3s binding to non-natural peptide 2c
7zmw
homo-2-mer1-231
4×MG;
Assess
Binary complex of 14-3-3 sigma and a high-affinity non-canonical 9-mer peptide binder
6tch
homo-2-mer1-231
8×MG; 2×CL;
Assess
Crystal structure of 14-3-3 sigma in complex with CIP2ApS904 peptide and stabilizing Fusicoccin A
7bmc
homo-2-mer1-231
2×FSC; 8×MG; 4×CL;
Assess
Human 14-3-3 sigma fused to the StARD1 peptide including phosphoserine-57
6t5h
homo-2-mer1-231
3×PGE; 1×IMD;
Assess
14-3-3 in complex with Pyrin pS208
8c2d
homo-2-mer1-231
8×MG;
Assess
Structure of 14-3-3 sigma delta C with electrophilic peptide 4IEA-5
8c2e
homo-2-mer1-231
2×TJI; 2×MG; 6×CL;
Assess
Molecular tweezers modulate 14-3-3 protein-protein interactions.
5oeh
homo-2-mer1-231
2×9SZ; 2×CL; 2×GOL;
Assess
Crystal structure of the human sigma isoform of 14-3-3 in complex with a mode-1 phosphopeptide
1ywt
homo-2-mer1-231
1×CA;
Assess
Ligand-free state of human 14-3-3 sigma isoform
6tlg
homo-2-mer1-231
2×PEG; 12×SO4;
Assess
14-3-3 sigma complexed with a phosphorylated 16E6 peptide
6twz
homo-2-mer1-231
2×TAR;
Assess
human 14-3-3 sigma isoform in complex with IMP
6tlf
homo-2-mer1-231
2×IMP; 2×SO4;
Assess
Human 14-3-3 sigma isoform in complex with PLP
6tm7
homo-2-mer1-231
1×PLP; 2×SO4;
Assess
Molecular tweezers modulate 14-3-3 protein-protein interactions
5oeg
homo-2-mer1-231
2×9SZ; 2×CL;
Assess
CH1 chimera of human 14-3-3 sigma with the HSPB6 phosphopeptide in a conformation with self-bound p…
5okf
homo-2-mer1-231
11×CD;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3cu8.1.Ahomo-2-mer0.841-232
1×ARG; 1×ARG; 1×MG; 1×PPI;69.67
Assess